NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

PreMarket Prep Stock Of The Day: What's Ailing Rite Aid?

Published 07/04/2022, 21:10
Updated 07/04/2022, 21:40
© Reuters.  PreMarket Prep Stock Of The Day: What's Ailing Rite Aid?
US90274J5618=UBSS
-
IX
-

It is a rarity when Wall Street analysts come out with a “sell” rating on a company. Yet in this market environment, when it occurs, it has a notable impact on the company being targeted.

That is certainly the case with Rite Aid Corporation (NYSE: RAD), which is the PreMarket Prep Stock Of The Day.

Serial Underperformer Since 2017: On a reverse split-adjusted basis, Rite Aid made its all-time in January 2017 at $175.40. At its current price of $6.20, that is a negative return of 96%.

Over the same period of time, from the January 2017 high (2,301) for the S&P 500 cash index to its current price (4,459), the index yielded a return of 94%. That makes for a disparity of nearly 200%.

Not A Good Year For Rite Aid: After ending 2021 at $14.69, the issue was in the red by 43% at Wednesday’s closing price of $8.44. Of course, that has increased with the sharp decline in Thursday’s session.

So far in 2022, the S&P 500 index is in the red as well, by only 6.4%.

The Ax: Before the open, Deutsche Bank (DE:DBKGn) analyst George Hill downgraded the stock from Hold to Sell and lowered the price target from $16 to $1.

In his opinion, the company is in decline and may be running low on cash. The lingering effects of the pandemic may have had a lasting impact on retail pharmacies, the analyst said.

PreMarket Prep's Take On Rite Aid: When the issue was being discussed on the show, it was trading at the $7 area. Co-host Dennis Dick agreed with the downgrade wholeheartedly.

“I thought this issue was a zero five years ago,” he said.

Obviously, I have been wrong as the stock rallied to $32 in January 2021, but I am sticking with my opinion.”

The author of this article noted the issue was $3 below its March 2020 low and there were no monthly support levels to be found. Also, if the premarket low ($6.60) is breached, there may be more follow through to the downside.

RAD Price Action: After a much lower open ($7 vs. $8.44), the issue had a brief rally to $7.14 and resumed its move lower.

Rite Aid stock ultimately lost 17.18% Thursday, closing at $6.99, according to Benzinga Pro.

The discussion on the issue from Thursday’s show can be found here:

Latest Ratings for RAD

DateFirmActionFromTo
Jun 2021JP MorganDowngradesNeutralUnderweight
Sep 2020Deutsche BankMaintainsHold
Apr 2020Deutsche BankUpgradesSellHold
View More Analyst Ratings for RAD

View the Latest Analyst Ratings

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.